Ji Hyoun Cha

Title: Ji Hyoun Cha: Inventor in Pneumococcal Vaccine Research

Introduction

Ji Hyoun Cha is an inventor based in Incheon, South Korea, and works at Celltrion Inc. His patent work concerns a multivalent immunogenic composition designed to broaden protection against pneumococcal serotypes.

Latest Patents

Cha is associated with 1 patent, titled “Immunogenic Composition Comprising Multivalent Polysaccharide-Protein Conjugates.” The invention describes a composition containing pneumococcal capsular polysaccharides from multiple serotypes, each conjugated to a carrier protein. It combines serotypes included in conventional vaccines with additional serotypes, including 10A, 11A, 12F, 15B, 22F, 23A, and 35B.

The patent describes the composition as intended to induce immune responses against a wider range of pneumococcal serotypes than Prevenar 13. Its proposed broader coverage includes serotypes relevant across Asia as well as Europe and North America, with potential use in preventing pneumococcal diseases in infants, children, and adults.

Career Highlights

Cha’s listed work at Celltrion Inc. connects his inventive activity with vaccine and immunogenic-composition research. The patent focuses on expanding the range of pneumococcal serotypes addressed by a single composition.

Collaborations

Cha’s named coworkers include Kyung Min Jo and Pan Kyeom Kim. Their inclusion alongside Cha reflects a collaborative context for the patent work.

Conclusion

Ji Hyoun Cha’s patent centers on a multivalent pneumococcal vaccine composition intended to broaden serotype coverage, highlighting his contribution to vaccine-related innovation at Celltrion Inc.